Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Acta Oncologica (Stockholm, Sweden)|July 20, 2021
Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impactSari Voutilainen, Päivi Heikkilä, Mika Sampo, et al.
BJS Open|August 11, 2022
Delay in the initiation of adjuvant chemotherapy in patients with breast cancer with mastectomy with or without immediate breast reconstructionTuomas Huttunen, Marjut Leidenius, Tiina Jahkola, et al.
Acta Oncologica (Stockholm, Sweden)|September 12, 2023
Predictive factors for prolonged sick leave in breast cancer patients treated with adjuvant therapies: a retrospective registry studyRiikka-Leena Leskelä, Ira Haavisto, Paula Pennanen, et al.
Clinical Breast Cancer|April 2, 2026
Impact of Preoperative MRI on Surgical and Long-term Outcome in Patients With Invasive Lobular Carcinoma (ILC): A Retrospective Cohort StudyMichaela S Björnström, Laura Niinikoski, Anders Ståhls, et al.
Breast Cancer Research and Treatment|March 12, 2021
Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trialMária Faltinová, Leena Vehmanen, Heli Lyytinen, et al.
Oncology|October 4, 2018
Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2ANelli Roininen, Sari Takala, Kirsi-Maria Haapasaari, et al.
Breast Cancer Research and Treatment|July 26, 2023
Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC-MS/MS (liquid chromatography-tandem mass spectrometry) method for estrogen measurementMária Faltinová, Leena Vehmanen, Heli Lyytinen, et al.
Acta Oncologica (Stockholm, Sweden)|February 19, 2026
Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancerJohanna Mattson, Meeri Maunu, Juho Lähteenmaa, et al.
BMC Cancer|January 26, 2017
Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical studyNelli Roininen, Sari Takala, Kirsi-Maria Haapasaari, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2023
Digital solution in the follow-up of early breast cancer a randomized studyJohanna Mattson, Maria Peltola, Paula Poikonen-Saksela, et al.
Pageof 6